IMPACT BIOMEDICAL INC.
IBONYSEHealthcare · Pharmaceutical Preparations · NV · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | |
|---|---|---|---|---|
| Revenue | $32,000 | — | — | $50,000 |
| Operating income | −$4.3M | −$28.8M | −$4.0M | −$3.4M |
| Net income | −$11.8M | −$24.7M | −$4.3M | −$7.3M |
| Total assets | $17.4M | $20.3M | $44.6M | $46.5M |
| Total liabilities | $1.9M | $13.1M | $16.4M | $13.8M |
| Equity | $12.6M | $4.3M | $25.2M | $29.6M |
| EPS (diluted) | $-0.38 | $-2.30 | $-0.07 | $-0.10 |
| Shares out. | 12.1M | 10.0M | 125.1M | 70.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −13381.3%
- Net margin
- −36993.8%
- Return on equity
- −93.9%
- Return on assets
- −68.0%
- Return on capital (ROCE)
- −26.4%
- Liabilities / assets
- 10.6%
- Debt / equity
- 0.15×
- Book value / share
- $1.04
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -4.05distress
- Accruals / assets
- −57.2%clean
- Piotroski F-Score
- 4/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 3 warning● 2 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Chan Heng Fai AmbroseActivist (13D)Apr 4, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 783,895 | 13.7 | -22.5% |
| Apr 30, 2026 | 1.0M | 10.7 | -16.5% |
| Apr 15, 2026 | 1.2M | 8.0 | -36.7% |
| Mar 31, 2026 | 1.9M | 2.1 | +45.3% |
| Mar 13, 2026 | 1.3M | 1.0 | +765.2% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreementMar 4, 2026
- Shareholder voteNov 6, 2025
- Other material eventOct 27, 2025
- Entered a material agreementJul 28, 2025
- Entered a material agreement · Regulation FD disclosureJun 23, 2025
- Entered a material agreementApr 3, 2025
- Entered a material agreementMar 28, 2025
- Director / officer changeMar 13, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.